Download | < Back |
10 May 2017 | |
The audited standalone and consolidated financial results for the quarter and year ended 31st March, 2017 of the Company under Ind AS (Statement), which were approved and taken on record at a meeting of the Board of Directors of the Company held on Wednesday, the 3rd May, 2017, were submitted to the stock exchanges thereafter. We enclose herewith the revised Statement as advised by your e-mail dated 5th May, 2017. Kindly note that the figures as reported earlier remain unchanged. | |
View all announcements for ALEMBIC PHARMACEUTICALS LTD. | Source: BSE India |